The success of brequinar, one of the most potent human dihydroorotate dehydrogenase (hDHODH) inhibitors, able to induce in vitro and in vivo myeloid differentiation in mouse acute myeloid leukaemia (AML) models [1], encourages researches to design new hDHODH inhibitors. By applying innovative scaffold-hopping replacement to brequinar, we designed a first generation of hDHODH inhibitors presenting nM activity [2]. In this occasion, we are presenting a second generation able to reach the brequinar hDHODH potency. Compound 1 was found also able to restore the myeloid differentiation in two leukaemia cell lines (U937 and THP-1) at concentrations one digit lower than brequinar. Theoretical design, modelling, synthesis, SAR, X-ray crystallographic data, biological assays, drug-like proprieties and in vivo toxicity are here presented and discussed.

PROCEEDINGS OF THE MERCK & ELSEVIER YOUNG CHEMISTSSYMPOSIUM

Stefano Sainas;Agnese C. Pippione;Davide Bonanni;Marta Giorgis;Elisa Lupino;Enrico Giraudo;Paola Circosta;Valentina Gaidano;Alessandro Cignetti;Marco Piccinini;Giuseppe Saglio;Salam Al-Karadaghi;Donatella Boschi;Marco L. Lolli
2018-01-01

Abstract

The success of brequinar, one of the most potent human dihydroorotate dehydrogenase (hDHODH) inhibitors, able to induce in vitro and in vivo myeloid differentiation in mouse acute myeloid leukaemia (AML) models [1], encourages researches to design new hDHODH inhibitors. By applying innovative scaffold-hopping replacement to brequinar, we designed a first generation of hDHODH inhibitors presenting nM activity [2]. In this occasion, we are presenting a second generation able to reach the brequinar hDHODH potency. Compound 1 was found also able to restore the myeloid differentiation in two leukaemia cell lines (U937 and THP-1) at concentrations one digit lower than brequinar. Theoretical design, modelling, synthesis, SAR, X-ray crystallographic data, biological assays, drug-like proprieties and in vivo toxicity are here presented and discussed.
2018
Proceedings of the Merck & Elsevier Young Chemists Symposium (MEYCS 2018
Rimini
19/11/2018 - 21/11/2018
Proceedings of the Merck & Elsevier Young Chemists Symposium (MEYCS 2018
Società Chimica Italiana
97
97
9788894952032
Stefano Sainas, Agnese C. Pippione, Davide Bonanni, Marta Giorgis, Elisa Lupino, Enrico Giraudo, Paola Circosta, Valentina Gaidano, Alessandro Cignett...espandi
File in questo prodotto:
File Dimensione Formato  
Book of abstracts.pdf

Accesso aperto

Descrizione: Book of Abstract
Tipo di file: PDF EDITORIALE
Dimensione 6.98 MB
Formato Adobe PDF
6.98 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1689218
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact